Search research articles
Contact Us
Filters
Showing results (61-70 of 130) with videos related to
Page
of 13
Sort By:
World Journal of Urology
|
July 7, 2025
Rectal spacer use and bowel, urinary, and sexual dysfunction diagnosis and related procedures among men receiving prostate radiotherapy: US county-level analysis
James B Yu, Michael R Folkert, Ryoko Sato, et al.
Radiation Oncology (London, England)
|
March 14, 2024
Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer
Elizabeth E Dong, Junqian Xu, Joo-Won Kim, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
October 4, 2014
The impact of numeracy on verbatim knowledge of the longitudinal risk for prostate cancer recurrence following radiation therapy
Daniel A Hamstra, Skyler B Johnson, Stephanie Daignault, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics
|
May 12, 2012
Predicting treatment efficacy via quantitative magnetic resonance imaging: a Bayesian joint model
Jincao Wu, Timothy D Johnson, Craig J Galbán, et al.
Journal of Pediatric Orthopedics
|
August 23, 2013
Osteochondromas after radiation for pediatric malignancies: a role for expanded counseling for skeletal side effects
Elizabeth A King, David A Hanauer, Sung Won Choi, et al.
Cancer
|
November 21, 2014
Impact of biochemical failure classification on clinical outcome: a secondary analysis of Radiation Therapy Oncology Group 9202 and 9413
Daniel A Hamstra, Kyounghwa Bae, Gerald Hanks, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 16, 2011
Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation
Aaron Sabolch, Felix Y Feng, Stephanie Daignault-Newton, et al.
Pediatric Blood & Cancer
|
August 30, 2019
Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysis
Thomas J Quinn, Muayad F Almahariq, Zaid A Siddiqui, et al.
Head & Neck
|
February 24, 2018
Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer
Daniel A Hamstra, Kuei C Lee, Avraham Eisbruch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2010
Pharmacokinetic analysis and phase 1 study of MRX-1024 in patients treated with radiation therapy with or without cisplatinum for head and neck cancer
Daniel A Hamstra, Avraham Eisbruch, Maddireddy U R Naidu, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 130) with videos related to
Sort By:
Page
of 13
World Journal of Urology
|
July 7, 2025
Rectal spacer use and bowel, urinary, and sexual dysfunction diagnosis and related procedures among men receiving prostate radiotherapy: US county-level analysis
James B Yu, Michael R Folkert, Ryoko Sato, et al.
Radiation Oncology (London, England)
|
March 14, 2024
Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer
Elizabeth E Dong, Junqian Xu, Joo-Won Kim, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
October 4, 2014
The impact of numeracy on verbatim knowledge of the longitudinal risk for prostate cancer recurrence following radiation therapy
Daniel A Hamstra, Skyler B Johnson, Stephanie Daignault, et al.
Journal of the Royal Statistical Society. Series C, Applied Statistics
|
May 12, 2012
Predicting treatment efficacy via quantitative magnetic resonance imaging: a Bayesian joint model
Jincao Wu, Timothy D Johnson, Craig J Galbán, et al.
Journal of Pediatric Orthopedics
|
August 23, 2013
Osteochondromas after radiation for pediatric malignancies: a role for expanded counseling for skeletal side effects
Elizabeth A King, David A Hanauer, Sung Won Choi, et al.
Cancer
|
November 21, 2014
Impact of biochemical failure classification on clinical outcome: a secondary analysis of Radiation Therapy Oncology Group 9202 and 9413
Daniel A Hamstra, Kyounghwa Bae, Gerald Hanks, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 16, 2011
Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation
Aaron Sabolch, Felix Y Feng, Stephanie Daignault-Newton, et al.
Pediatric Blood & Cancer
|
August 30, 2019
Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysis
Thomas J Quinn, Muayad F Almahariq, Zaid A Siddiqui, et al.
Head & Neck
|
February 24, 2018
Double-blind placebo-controlled multicenter phase II trial to evaluate D-methionine in preventing/reducing oral mucositis induced by radiation and chemotherapy for head and neck cancer
Daniel A Hamstra, Kuei C Lee, Avraham Eisbruch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2010
Pharmacokinetic analysis and phase 1 study of MRX-1024 in patients treated with radiation therapy with or without cisplatinum for head and neck cancer
Daniel A Hamstra, Avraham Eisbruch, Maddireddy U R Naidu, et al.
Page
of 13